Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

GTX-0196 shows complete tumor growth suppression in models of AML

May 4, 2022

Hemispherian closes seed funding to advance preclinical pipeline for cancer

May 3, 2022

Storm Therapeutics identifies new METTL3 inhibitors

May 3, 2022

New EGFR inhibitors discovered at the Dana-Farber Cancer Institute

May 3, 2022

OQL-051 shows prophylactic efficacy in models of chemotherapy-induced diarrhea

May 3, 2022

Bridge Biotherapeutics and Cyrus Therapeutics generate next-generation EGFR degraders

May 2, 2022

BioNova Pharmaceuticals menin inhibitor BNM-1192 shows promise for MLL rearranged leukemias

May 2, 2022

New KCNA3 channel blockers identified at DE Shaw Research

May 2, 2022

BBT-207, a fourth-generation EGFR TKI with activity against most common mutants

May 2, 2022

Discovery of pyrrolo-pyridine benzamide derivative with promising antitumor efficacy in vivo

April 29, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...